Article
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
Molecular psychiatry - 1 Nov 1998
Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M
Abstract excerpt
Depression with psychotic features has been shown to respond to selective serotonin reuptake inhibitors (SSRIs). The serotonin transporter (5-HTT) is a prime target for SSRIs. A functional polymorphism within the promoter region of the 5-HTT gene, leading to different transcriptional efficiency, was recently reported. We tested the hypothesis that allelic variation of the 5-HTT promoter could be related to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
